Live feed02:00:00·9dPRReleasevia QuantisnowPhase 3 ASSURE Interim Data: Majority of People in the Study with ALP 1–1.67×ULN Achieved High and Sustained Composite ALP Normalization at 24 Months with Gilead's Livdelzi (Seladelpar)ByQuantisnow·Wall Street's wire, on your screen.GILD· Gilead Sciences Inc.Health Care
